Screener
Taysha Gene Therapies, Inc. TSHA PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344610
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 6,027 | 4,431 |
| Total current assets | 461,434 | 324,647 |
| Restricted cash | 164 | 2,315 |
| Property, plant and equipment, net | 2,412 | 6,736 |
| Operating lease right-of-use assets | 6,317 | 9,439 |
| Other non-current assets | 106 | 183 |
| Total assets | $470,433 | $343,320 |
| LIABILITIES AND STOCKHOLDERS' EQUITY |
Item 1. Financial Statements.
FAQ
- What is Taysha Gene Therapies, Inc.'s PP&E (net)?
- Taysha Gene Therapies, Inc. (TSHA) reported PP&E (net) of $2.41M in Q2 2026.
- How has Taysha Gene Therapies, Inc.'s PP&E (net) changed year-over-year?
- Taysha Gene Therapies, Inc.'s PP&E (net) decreased by 65.3% year-over-year, from $6.96M to $2.41M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s PP&E (net) has grown at a 88.0% compound annual growth rate (CAGR), from $287K to $6.74M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Taysha Gene Therapies, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude